Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Human Vaccines & Immunotherapeutics
|
April 20, 2018
Cell culture-derived flu vaccine: Present and future
Alberto Pérez Rubio, Jose María Eiros
Gaceta Sanitaria
|
July 2, 2013
[An experience of the use of cell culture-derived influenza vaccines in an influenza vaccination campaign]
Alberto Pérez-Rubio, Jose María Eiros Bouza
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
February 19, 2015
[Burden of influenza virus type B and mismatch with the flu vaccine in Spain]
Jose Ma Eiros-Bouza, Alberto Pérez-Rubio
Atencion Primaria
|
February 10, 2015
[Ebola and emerging viruses]
José María Eiros Bouza, Alberto Pérez-Rubio
Human Vaccines & Immunotherapeutics
|
April 8, 2020
Quadrivalent cell culture influenza virus vaccine. Comparison to egg-derived vaccine
Alberto Pérez-Rubio, Julio Ancochea, Jose María Eiros Bouza
Gaceta Sanitaria
|
September 13, 2020
[Flu vaccination as the most effective measure to face the clinical and economic impact of the complaint]
Miguel López-Gobernado, Alberto Pérez-Rubio, José María Eiros
Medicina Clinica
|
January 10, 2019
Seasonal influenza in Spain: Clinical and economic burden and vaccination programmes
Alberto Pérez-Rubio, Leticia Platero, José María Eiros Bouza
Gaceta Sanitaria
|
July 2, 2013
[Nosocomial flu infection]
Alberto Pérez-Rubio, Socorro Fernández Arribas, José María Eiros Bouza
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
June 3, 2015
[Comment on "Evolution of the serotype coverage for the current anti-pneumococcal vaccines"]
Alberto Pérez-Rubio, Jose Maria Eiros-Bouza, Maria Rosario Bachiller
Atencion Primaria
|
March 10, 2020
[Pneumococcal vaccine for adults over 65]
Miguel López Gobernado, Alberto Pérez-Rubio, José María Eiros Bouza
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Human Vaccines & Immunotherapeutics
|
April 20, 2018
Cell culture-derived flu vaccine: Present and future
Alberto Pérez Rubio, Jose María Eiros
Gaceta Sanitaria
|
July 2, 2013
[An experience of the use of cell culture-derived influenza vaccines in an influenza vaccination campaign]
Alberto Pérez-Rubio, Jose María Eiros Bouza
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
February 19, 2015
[Burden of influenza virus type B and mismatch with the flu vaccine in Spain]
Jose Ma Eiros-Bouza, Alberto Pérez-Rubio
Atencion Primaria
|
February 10, 2015
[Ebola and emerging viruses]
José María Eiros Bouza, Alberto Pérez-Rubio
Human Vaccines & Immunotherapeutics
|
April 8, 2020
Quadrivalent cell culture influenza virus vaccine. Comparison to egg-derived vaccine
Alberto Pérez-Rubio, Julio Ancochea, Jose María Eiros Bouza
Gaceta Sanitaria
|
September 13, 2020
[Flu vaccination as the most effective measure to face the clinical and economic impact of the complaint]
Miguel López-Gobernado, Alberto Pérez-Rubio, José María Eiros
Medicina Clinica
|
January 10, 2019
Seasonal influenza in Spain: Clinical and economic burden and vaccination programmes
Alberto Pérez-Rubio, Leticia Platero, José María Eiros Bouza
Gaceta Sanitaria
|
July 2, 2013
[Nosocomial flu infection]
Alberto Pérez-Rubio, Socorro Fernández Arribas, José María Eiros Bouza
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
June 3, 2015
[Comment on "Evolution of the serotype coverage for the current anti-pneumococcal vaccines"]
Alberto Pérez-Rubio, Jose Maria Eiros-Bouza, Maria Rosario Bachiller
Atencion Primaria
|
March 10, 2020
[Pneumococcal vaccine for adults over 65]
Miguel López Gobernado, Alberto Pérez-Rubio, José María Eiros Bouza
Page
of 3